UbiquiTx Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

UbiquiTx General Information

Description

Developer of a computational platform designed for protein-modulating therapies. The company's platform leverages machine learning and protein engineering to identify peptide sequences, offering features like AI-powered target protein modulation and programmable protein degradation, enabling pharmaceutical industry to address previously difficult-to-target proteins and potentially create new treatments for a wide range of diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 325 Vassar Street
  • Cambridge, MA 02139
  • United States
Primary Industry
Biotechnology
Corporate Office
  • 325 Vassar Street
  • Cambridge, MA 02139
  • United States

UbiquiTx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UbiquiTx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 21-Nov-2024 Completed Generating Revenue
7. Accelerator/Incubator 30-Oct-2024 Completed Generating Revenue
6. Accelerator/Incubator 01-Sep-2024 Completed Generating Revenue
5. Grant 01-Jan-2024 Completed Generating Revenue
4. Accelerator/Incubator 01-Jul-2023 Completed Generating Revenue
3. Seed Round 05-Apr-2023 Completed Generating Revenue
2. Accelerator/Incubator 14-Oct-2022 Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view UbiquiTx’s complete valuation and funding history, request access »

UbiquiTx Patents

UbiquiTx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240335554-A1 Post-translational modification chimeric molecule Pending 04-Apr-2023
EP-4616405-A2 Sequence-based framework to design peptide-guided degraders Pending 07-Nov-2022
EP-4616405-A4 Sequence-based framework to design peptide-guided degraders Pending 07-Nov-2022
US-20260188424-A1 Sequence-based framework to design peptide-guided degraders Pending 07-Nov-2022
WO-2024102733-A2 Sequence-based framework to design peptide-guided degraders Inactive 07-Nov-2022 G16B15/30
To view UbiquiTx’s complete patent history, request access »

UbiquiTx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UbiquiTx Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mass Innovation Network Accelerator/Incubator
Merck Digital Sciences Studio Accelerator/Incubator Minority
The Engine Accelerator/Incubator
US National Science Foundation Accelerator/Incubator
National Institutes of Health Government Minority
You’re viewing 5 of 9 investors. Get the full list »

UbiquiTx FAQs

  • When was UbiquiTx founded?

    UbiquiTx was founded in 2020.

  • Where is UbiquiTx headquartered?

    UbiquiTx is headquartered in Cambridge, MA.

  • What is the size of UbiquiTx?

    UbiquiTx has 4 total employees.

  • What industry is UbiquiTx in?

    UbiquiTx’s primary industry is Biotechnology.

  • Is UbiquiTx a private or public company?

    UbiquiTx is a Private company.

  • What is UbiquiTx’s current revenue?

    The current revenue for UbiquiTx is .

  • How much funding has UbiquiTx raised over time?

    UbiquiTx has raised $400K.

  • Who are UbiquiTx’s investors?

    Mass Innovation Network, Merck Digital Sciences Studio, The Engine, US National Science Foundation, and National Institutes of Health are 5 of 9 investors who have invested in UbiquiTx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process